MangoRx vs MEDVi: Which GLP-1 Provider Is Better?
A side-by-side comparison of MangoRx and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
MangoRx
#29 of 317.5/10
Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
Visit MangoRxHigher Rated
MEDVi
#9 of 318.3/10
Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | MangoRx | MEDVi |
|---|---|---|
| Our Score | 7.5/10 | 8.3/10 |
| Starting Price | $195/mo | $179/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a multi-service telehealth platform covering weight loss and men's health | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #29 | #9 |
Pros & Cons Compared
MangoRx
Pros
- +Multi-service platform
- +Compounded options
- +Men's health services
- +One-stop shop
Cons
- −Compounded only
- −No insurance
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out MangoRx with a score of 8.3/10 vs 7.5/10. If budget is your priority, MEDVi starts at $179/mo compared to MangoRx's $195/mo. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.